Use of a hydroxystilbene-containing active substance combination containing resveratrol and piceatannol precursors, to prevent and/or treat diseases caused by increased serum interleukin-6 level e.g. depression

摘要

Hydroxystilbene-containing active substance combination (I) containing at least two compounds, resveratrol and piceatannol precursors, their derivatives, stereoisomers, salts or phenolic forms, is used for preparing an agent (II) for the prevention and/or treatment of diseases caused by increased serum interleukin-6 (IL-6) level. Hydroxystilbene-containing active substance combination (I) containing at least two compounds, resveratrol and piceatannol precursors or their derivatives, stereoisomers, salts or phenolic forms, is used for preparing an agent (II) for the prevention and/or treatment of diseases caused by increased serum interleukin-6 (IL-6) level, where their occurrence and/or progress is treated by a dose of estrogen receptor-beta agonist. Independent claims are also included for: (1) a dosage form comprising active substance or (I) in a pharmaceutically or dietically acceptable carrier; and (2) an agent comprising the dosage form. ACTIVITY : Antidepressant; Antimigraine; Antiinflammatory; Cytostatic. MECHANISM OF ACTION : Estrogen receptor beta agonist; Interleukin-6 antagonist.